Cite
HARVARD Citation
Ledermann, J. et al. (n.d.). Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet oncology. 17 (11), pp. 1579-1589. [Online].